Journal
Signal Transduction and Targeted Therapy
Publication Date
8-18-2023
Volume
8
Issue
1
First Page
305
Document Type
Open Access Publication
DOI
10.1038/s41392-023-01539-9
Rights and Permissions
Lee, C., Chen, R., Sun, G. et al. VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway. Sig Transduct Target Ther 8, 305 (2023). https://doi.org/10.1038/s41392-023-01539-9 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Lee, Chunsik; Ornitz, David M; and et al., "VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway." Signal Transduction and Targeted Therapy. 8, 1. 305 (2023).
https://digitalcommons.wustl.edu/oa_4/2174
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
